Assessed with: number of 4/20 studies, range 0.0 to 2.5 % patients who died Renaud et al (2014) and Kitano et al (2012): 0/365 (0%) 30-day mortality MTA Observational serious 1 not serious not serious not serious none 1/739 (0.14%) CRITICAL ⨁⨀⨀⨀ Follow up: range 6 – 30 mths studies (k=16) VERY LOW Assessed with: n/N (%), per patient RFA Observational serious 1 not serious not serious Not serious none 2/810 (<0.1%) IMPORTANT ⨁⨀⨀⨀ studies (k=8) Follow up: range 10 – 36 mths VERY LOW Assessed with: n/N (%), per patient Radiotherapy Observational serious 3 not serious not serious not serious none No deaths within 30 days were reported IMPORTANT ⨁⨀⨀⨀ studies (k=17) by any study. Follow up: range 13 – 82 mths VERY LOW Assessed with: number of patients who died Surgery Observational serious 1 not serious not serious not serious none 10/1,499 (0.67%) IMPORTANT ⨁⨀⨀⨀ studies (k=4) Follow up: NA VERY LOW Assessed with: n/N (%), per patient Pneumothorax MTA Observational serious 1 not serious not serious not serious none n/N (%): 280/1025 (27.3) IMPORTANT ⨁⨀⨀⨀ Follow up: range 6 – 30 mths studies (k=22) Median: 30.2 (8.3 – 63.8) VERY LOW Assessed with: n/N (%), per ablations RFA Observational serious 1 not serious not serious not serious none Per ablation: IMPORTANT ⨁⨀⨀⨀ studies (k=19) Follow up: range 12 – 46 mths n/N (%):674/1497 (45%) VERY LOW Assessed with: n/N (%), per Median: 24% (9–67%) ablations and per patient Per patient:
Assessed with: number of patients who died 4/20 studies, range 0.0 to 2.5 % Renaud et al (2014) and Kitano et al (2012): 0/365 (0%) 30-day mortality MTA Follow up: range 6 – 30 mths Assessed with: n/N (%), per patient Observational studies (k=16) serious 1 not serious not serious not serious none 1/739 (0.14%) ⨁⨀⨀⨀ VERY LOW CRITICAL RFA Follow up: range 10 – 36 mths Assessed with: n/N (%), per patient Observational studies (k=8) serious 1 not serious not serious Not serious none 2/810 (<0.1%) ⨁⨀⨀⨀ VERY LOW IMPORTANT Radiotherapy Follow up: range 13 – 82 mths Assessed with: number of patients who died Observational studies (k=17) serious 3 not serious not serious not serious none No deaths within 30 days were reported by any study. ⨁⨀⨀⨀ VERY LOW IMPORTANT Surgery Follow up: NA Assessed with: n/N (%), per patient Observational studies (k=4) serious 1 not serious not serious not serious none 10/1,499 (0.67%) ⨁⨀⨀⨀ VERY LOW IMPORTANT Pneumothorax MTA Follow up: range 6 – 30 mths Assessed with: n/N (%), per ablations Observational studies (k=22) serious 1 not serious not serious not serious none n/N (%): 280/1025 (27.3) Median: 30.2 (8.3 – 63.8) ⨁⨀⨀⨀ VERY LOW IMPORTANT RFA Follow up: range 12 – 46 mths Assessed with: n/N (%), per ablations and per patient Observational studies (k=19) serious 1 not serious not serious not serious none Per ablation: n/N (%):674/1497 (45%) Median: 24% (9–67%) Per patient: ⨁⨀⨀⨀ VERY LOW IMPORTANT
1403%20-%20Final%20Contracted%20Assessment%20Report%20(ACCESSIBLE).docx